According to a new market report published by Lucintel, the future of the DNA diagnostic market looks promising with opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The global DNA diagnostic market is expected to grow with a CAGR of 11% from 2020 to 2025. The major drivers for this market are continuous product modifications, increased preference for efficient diagnostic platforms, and increased research & development activities
.To download report brochure, please go to https://www.lucintel.com/dna-diagnostic-market.aspx and click "download brochure" tab from the menu
DNA diagnostics is used to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. In this market, instruments, reagents, and service & software are the major products segments. Lucintel forecasts that instruments will remain the largest product segment over the forecast period due to improved healthcare facilities, availability of user-friendly instruments, their competitive cost structure, reliability, and size.
Within this market, infectious disease diagnostics will remain the largest application segment over the forecast period due to the increasing prevelance of infectious diseases, advantages of DNA testing in infectious diseases for early detection, and technological advancement for diagnostic application.
North America will remain the largest region over the forecast period due to the presence of sophisticated healthcare infrastructure, strong government initiatives, proactive funding for DNA testing research, and high prevalence of chronic diseases in the region.
GE Healthcare, Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide, Hologic, Transgenomic, Siemens Healthcare, Roche Diagnostics, and Qiagen are among the major suppliers in the global DNA diagnostic market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global DNA diagnostic market by product, technology, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global DNA Diagnostic Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global DNA diagnostic market by product, technology, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Instruments
Reagents
Service & Software
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Microarray Based
PCR (Polymerase Chain Reaction) Based
In-situ Hybridization
NGS (Next Generation Sequencing) DNA Diagnosis
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Pre-Natal DNA Carrier Screening
Pre-Implantation Diagnosis
Newborn Genetic Screening
Infectious Disease Diagnostics
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.